JP6930975B2 - 網膜裂孔をシーリングするためのパッチならびに関連するデバイス、システム、および方法 - Google Patents
網膜裂孔をシーリングするためのパッチならびに関連するデバイス、システム、および方法 Download PDFInfo
- Publication number
- JP6930975B2 JP6930975B2 JP2018530506A JP2018530506A JP6930975B2 JP 6930975 B2 JP6930975 B2 JP 6930975B2 JP 2018530506 A JP2018530506 A JP 2018530506A JP 2018530506 A JP2018530506 A JP 2018530506A JP 6930975 B2 JP6930975 B2 JP 6930975B2
- Authority
- JP
- Japan
- Prior art keywords
- patch
- cannula
- delivery device
- retina
- shaft
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010038848 Retinal detachment Diseases 0.000 title claims description 50
- 230000004264 retinal detachment Effects 0.000 title claims description 50
- 238000000034 method Methods 0.000 title description 37
- 238000007789 sealing Methods 0.000 title description 7
- 239000000853 adhesive Substances 0.000 claims description 68
- 230000001070 adhesive effect Effects 0.000 claims description 68
- 210000001525 retina Anatomy 0.000 claims description 41
- 238000001356 surgical procedure Methods 0.000 claims description 27
- 239000000463 material Substances 0.000 claims description 24
- 239000012530 fluid Substances 0.000 claims description 22
- 230000033001 locomotion Effects 0.000 claims description 14
- 239000000758 substrate Substances 0.000 claims description 10
- 230000002207 retinal effect Effects 0.000 claims description 9
- 239000000017 hydrogel Substances 0.000 claims description 6
- 239000003431 cross linking reagent Substances 0.000 claims description 4
- 238000003780 insertion Methods 0.000 claims description 4
- 230000037431 insertion Effects 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 230000000149 penetrating effect Effects 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 239000012620 biological material Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 description 16
- 230000007246 mechanism Effects 0.000 description 10
- 231100000241 scar Toxicity 0.000 description 8
- 230000003213 activating effect Effects 0.000 description 7
- 238000011065 in-situ storage Methods 0.000 description 7
- 230000000649 photocoagulation Effects 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 208000034693 Laceration Diseases 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 208000002367 Retinal Perforations Diseases 0.000 description 4
- 239000003855 balanced salt solution Substances 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 4
- 239000004810 polytetrafluoroethylene Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- -1 vitreous humor Substances 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 210000003786 sclera Anatomy 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 230000004393 visual impairment Effects 0.000 description 3
- 210000004127 vitreous body Anatomy 0.000 description 3
- 241001631457 Cannula Species 0.000 description 2
- 229920001651 Cyanoacrylate Polymers 0.000 description 2
- 102000016359 Fibronectins Human genes 0.000 description 2
- 108010067306 Fibronectins Proteins 0.000 description 2
- 102000007547 Laminin Human genes 0.000 description 2
- 108010085895 Laminin Proteins 0.000 description 2
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 206010047571 Visual impairment Diseases 0.000 description 2
- 239000000560 biocompatible material Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 108010014606 glutathione-bicarbonate-Ringer solution Proteins 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 229920000052 poly(p-xylylene) Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000002271 resection Methods 0.000 description 2
- 230000003746 surface roughness Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 208000029257 vision disease Diseases 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010022355 Fibroins Proteins 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 206010038897 Retinal tear Diseases 0.000 description 1
- 229910018503 SF6 Inorganic materials 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000005229 chemical vapour deposition Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- NLCKLZIHJQEMCU-UHFFFAOYSA-N cyano prop-2-enoate Chemical class C=CC(=O)OC#N NLCKLZIHJQEMCU-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 208000018769 loss of vision Diseases 0.000 description 1
- 231100000864 loss of vision Toxicity 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 238000002406 microsurgery Methods 0.000 description 1
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 1
- 229960004065 perflutren Drugs 0.000 description 1
- 238000005240 physical vapour deposition Methods 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- SFZCNBIFKDRMGX-UHFFFAOYSA-N sulfur hexafluoride Chemical compound FS(F)(F)(F)(F)F SFZCNBIFKDRMGX-UHFFFAOYSA-N 0.000 description 1
- 229960000909 sulfur hexafluoride Drugs 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 208000000318 vitreous detachment Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00491—Surgical glue applicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3468—Trocars; Puncturing needles for implanting or removing devices, e.g. prostheses, implants, seeds, wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00491—Surgical glue applicators
- A61B2017/005—Surgical glue applicators hardenable using external energy source, e.g. laser, ultrasound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00623—Introducing or retrieving devices therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00646—Type of implements
- A61B2017/00659—Type of implements located only on one side of the opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00727—Apparatus for retinal reattachment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Surgical Instruments (AREA)
- Prostheses (AREA)
- Medicinal Preparation (AREA)
Description
Claims (12)
- 眼科用手術システムであって、
網膜裂孔を囲む網膜に接着されたときに流体が網膜下空間に浸透するのを防ぐことにより目の前記網膜裂孔をシールするような大きさおよび形にされた生物分解性パッチであって、前記パッチは、前記網膜裂孔の大きさおよび形に応じた大きさおよび形にされており、前記パッチは、基体とされており、該基体に配置された材料を有する、生物分解性パッチと、
前記目における切込みを通過するために、内側において、前記パッチが、折り畳まれ、巻かれ、及び/又は、巻き収められた状態で配置されたカニューレを含む送達デバイスであって、前記送達デバイスが、折り畳まれ、巻かれ、及び/又は、巻き収められた状態の前記パッチを前記目の硝子体腔内で展開させるように作動可能であり、前記パッチは、前記網膜裂孔を取り囲む網膜に接着されたときに、前記網膜裂孔を完全にシールするような大きさ及び形にされている、送達デバイスと、
前記パッチを前記網膜に貼り付けるために前記パッチ上に配置された生物適合性接着剤と、
を含む眼科用手術システム。 - 前記パッチが、ハイドロゲル、生物学的材料、エラストマー性ポリマー、架橋剤、または硬化剤の少なくとも1つを含む、請求項1に記載のシステム。
- 前記接着剤が液体への露出時に活性化される、請求項1に記載のシステム。
- 前記接着剤が光への露出時に活性化される、請求項1に記載のシステム。
- 前記硝子体腔内への挿入のための大きさおよび形にされたアプリケータであって、前記パッチが前記網膜に位置付けられている間に前記接着剤を前記パッチの少なくとも外周に塗布するように構成されたアプリケータをさらに含む、請求項1に記載のシステム。
- 前記送達デバイスが、前記カニューレに結合された本体であって、ユーザが把持するための大きさおよび形にされた本体をさらに含む、請求項1に記載のシステム。
- 前記送達デバイスが、前記カニューレ内に移動可能に配置されたシャフトを含み、前記シャフトが、前記シャフトの移動時に前記パッチを前記カニューレから出すように構成される、請求項6に記載のシステム。
- 前記シャフトが、前記シャフトの移動を制御する作動制御部に結合される、請求項7に記載のシステム。
- 前記作動制御部が、前記送達デバイスの前記本体に配置される、請求項8に記載のシステム。
- 眼科用手術システムであって、
本体と、前記本体に結合されたカニューレと、前記カニューレ内に移動可能に配置されたシャフトとを含む送達デバイスであって、前記カニューレが、目の硝子体腔に挿入されるような大きさおよび形にされた、送達デバイスと、
網膜裂孔を取り囲む網膜に接着されたときに前記網膜裂孔を完全にシールするような大きさおよび形にされた生物分解性パッチであって、前記パッチは、前記網膜裂孔の大きさおよび形に応じた大きさおよび形にされており、前記目における切込みを通過するために、前記カニューレ内に、折り畳まれ、巻かれ、及び/又は、巻き収められた状態で配置され、前記シャフトの作動時、前記パッチが前記カニューレから出されて前記硝子体腔に入り、前記パッチが広げられた状態へ調整可能とされており、前記パッチは、基体とされており、該基体に配置された材料を有する、生物分解性パッチと、
前記パッチを前記網膜に貼り付けるために前記パッチ上に配置された生物適合性接着剤と、を含んでおり、
前記送達デバイスは、折り畳まれ、巻かれ、及び/又は、巻き収められた状態の前記パッチを前記目の前記硝子体腔内で展開させるように作動可能とされている、眼科用手術システム。 - 前記パッチは、透明である、請求項1に記載のシステム。
- 前記パッチは、透明である、請求項10に記載のシステム。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021093263A JP7177887B2 (ja) | 2015-12-14 | 2021-06-02 | 網膜裂孔をシーリングするためのパッチならびに関連するデバイス、システム、および方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562266995P | 2015-12-14 | 2015-12-14 | |
US62/266,995 | 2015-12-14 | ||
PCT/IB2016/057439 WO2017103744A1 (en) | 2015-12-14 | 2016-12-08 | Patch for sealing retinal breaks and associated devices, systems, and methods |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021093263A Division JP7177887B2 (ja) | 2015-12-14 | 2021-06-02 | 網膜裂孔をシーリングするためのパッチならびに関連するデバイス、システム、および方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2019501701A JP2019501701A (ja) | 2019-01-24 |
JP6930975B2 true JP6930975B2 (ja) | 2021-09-01 |
Family
ID=57614406
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018530506A Active JP6930975B2 (ja) | 2015-12-14 | 2016-12-08 | 網膜裂孔をシーリングするためのパッチならびに関連するデバイス、システム、および方法 |
JP2021093263A Active JP7177887B2 (ja) | 2015-12-14 | 2021-06-02 | 網膜裂孔をシーリングするためのパッチならびに関連するデバイス、システム、および方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021093263A Active JP7177887B2 (ja) | 2015-12-14 | 2021-06-02 | 網膜裂孔をシーリングするためのパッチならびに関連するデバイス、システム、および方法 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20170165109A1 (ja) |
EP (1) | EP3389576B1 (ja) |
JP (2) | JP6930975B2 (ja) |
CN (1) | CN108366875A (ja) |
AU (1) | AU2016370711B2 (ja) |
CA (1) | CA3006032A1 (ja) |
WO (1) | WO2017103744A1 (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201722377A (zh) | 2015-12-16 | 2017-07-01 | 諾華公司 | 用於插管遞送式治療材料施加裝置之裝置及方法 |
TW201815356A (zh) | 2016-10-18 | 2018-05-01 | 諾華公司 | 具有表面紋理的外科手術器械 |
DE102017223006A1 (de) * | 2017-12-18 | 2019-06-19 | Geuder Ag | Vorrichtung zum Einbringen eines Mediums in das menschliche oder tierische Auge |
WO2020018843A1 (en) * | 2018-07-19 | 2020-01-23 | Sanulus Medical, LLC | Devices and methods for targeted delivery of a substance |
US20220346876A1 (en) | 2018-07-19 | 2022-11-03 | Sanulus Medical, LLC | Devices and methods for targeted delivery of a substance |
US20220008250A1 (en) * | 2020-07-07 | 2022-01-13 | Sanulus Medical, LLC | Devices and methods for targeted delivery of material |
WO2020227705A1 (en) * | 2019-05-09 | 2020-11-12 | Soliman Sherif | Hydrogel retinal tamponade agent |
EP4027898A1 (en) * | 2019-09-13 | 2022-07-20 | HoliStick Medical | Medical implant, delivery device, method of producing a medical implant, and method of delivering a medical implant |
CN112472414A (zh) * | 2020-12-14 | 2021-03-12 | 中国人民解放军总医院 | 钉式视网膜裂孔封闭器及植入器 |
WO2024015900A1 (en) * | 2022-07-15 | 2024-01-18 | Sanulus Medical, LLC | Devices and methods for targeted delivery of a substance |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3618594A (en) * | 1970-04-06 | 1971-11-09 | Surgical Design Corp | Ultrasonic apparatus for retinal reattachment |
SG49267A1 (en) * | 1989-08-14 | 1998-05-18 | Photogenesis Inc | Surgical instrument and cell isolation and transplantation |
US5817075A (en) * | 1989-08-14 | 1998-10-06 | Photogenesis, Inc. | Method for preparation and transplantation of planar implants and surgical instrument therefor |
US5180362A (en) * | 1990-04-03 | 1993-01-19 | Worst J G F | Gonio seton |
US5597381A (en) * | 1993-06-03 | 1997-01-28 | Massachusetts Eye And Ear Infirmary | Methods for epi-retinal implantation |
US5468246A (en) * | 1993-07-02 | 1995-11-21 | Iovision, Inc. | Intraocular lens injector |
US5527356A (en) * | 1994-08-02 | 1996-06-18 | Syntec, Inc. | Retinal plug |
US5868728A (en) * | 1995-02-28 | 1999-02-09 | Photogenesis, Inc. | Medical linear actuator for surgical delivery, manipulation, and extraction |
US5941250A (en) * | 1996-11-21 | 1999-08-24 | University Of Louisville Research Foundation Inc. | Retinal tissue implantation method |
US6024719A (en) * | 1998-07-06 | 2000-02-15 | Morris; Robert E | Method and apparatus for performing surgery inside the human retina using fluidic internal limiting membrane (ILM) seperation (FILMS) |
US6428234B1 (en) * | 2000-01-07 | 2002-08-06 | Closure Medical Corporation | Adhesive applicator tips with improved flow properties |
US7708711B2 (en) * | 2000-04-14 | 2010-05-04 | Glaukos Corporation | Ocular implant with therapeutic agents and methods thereof |
AU2002363315A1 (en) * | 2001-10-19 | 2003-05-19 | Innovative Retinal Products Llc | Macula cover and method |
US7255874B1 (en) * | 2001-12-21 | 2007-08-14 | Closure Medical Corporation | Biocompatible polymers and adhesives: compositions, methods of making and uses related thereto |
US7220224B1 (en) * | 2003-03-07 | 2007-05-22 | Minu, Llc | Retinal translocation and fixation using adhesive material |
US20050182443A1 (en) * | 2004-02-18 | 2005-08-18 | Closure Medical Corporation | Adhesive-containing wound closure device and method |
US20060258994A1 (en) * | 2005-05-12 | 2006-11-16 | Avery Robert L | Implantable delivery device for administering pharmacological agents to an internal portion of a body |
CN101360523B (zh) * | 2006-01-17 | 2013-05-29 | 创森德医疗设备公司 | 青光眼治疗装置 |
US20070255402A1 (en) * | 2006-05-01 | 2007-11-01 | Moore Jacob J | Wound closure method |
EP2063789A2 (en) * | 2006-10-03 | 2009-06-03 | Arsenal Medical, Inc. | Articles and methods for tissue repair |
US8080593B2 (en) * | 2006-11-29 | 2011-12-20 | University Of Southern California | Reversible thermoresponsive adhesives for implants |
EP2173289A4 (en) * | 2007-07-17 | 2010-11-24 | Transcend Medical Inc | EYE IMPLANT WITH HYDROGEL EXPANSION CAPABILITIES |
ES2593841T3 (es) * | 2007-11-19 | 2016-12-13 | Massachusetts Institute Of Technology | Artículos adhesivos |
US8617139B2 (en) * | 2008-06-25 | 2013-12-31 | Transcend Medical, Inc. | Ocular implant with shape change capabilities |
US8425473B2 (en) * | 2009-01-23 | 2013-04-23 | Iscience Interventional Corporation | Subretinal access device |
ES2786101T3 (es) * | 2009-01-28 | 2020-10-08 | Alcon Inc | Implante ocular con cualidades de rigidez, métodos y sistema de implantación |
US20120142603A1 (en) * | 2009-02-12 | 2012-06-07 | University Of Southern California | Bioadhesive patch for sutureless closure of soft tissue |
US8057483B2 (en) * | 2009-02-14 | 2011-11-15 | Ocular Transplantation Llc | Subretinal implantation instrument |
EP2405832A1 (en) * | 2009-03-10 | 2012-01-18 | IMI Intelligent Medical Implants AG | Device for sealing an incision |
SG176067A1 (en) * | 2009-05-15 | 2011-12-29 | Iscience Interventional Corp | Methods and apparatus for sub-retinal catheterization |
JP5937004B2 (ja) * | 2009-05-18 | 2016-06-22 | ドーズ メディカル コーポレーションDose Medical Corporation | 薬剤溶出眼内インプラント |
US20110029074A1 (en) * | 2009-08-03 | 2011-02-03 | Abbott Medical Optics Inc. | Fixation of ophthalmic implants |
US20110060320A1 (en) * | 2009-09-07 | 2011-03-10 | Chen Aharon-Attar | System and method for repairing tissue sections |
US8529492B2 (en) * | 2009-12-23 | 2013-09-10 | Trascend Medical, Inc. | Drug delivery devices and methods |
EP2359782A1 (en) * | 2010-02-03 | 2011-08-24 | nolax AG | Wound closure material |
US20120041427A1 (en) * | 2010-04-20 | 2012-02-16 | Minipumps, Llc | Electrolytically driven drug pump devices |
US8545430B2 (en) * | 2010-06-09 | 2013-10-01 | Transcend Medical, Inc. | Expandable ocular devices |
JP5996544B2 (ja) * | 2010-10-15 | 2016-09-21 | クリアサイド・バイオメディカル・インコーポレーテッドClearside Biomedical Incorporated | 眼球アクセス用装置 |
US9241832B2 (en) * | 2012-04-24 | 2016-01-26 | Transcend Medical, Inc. | Delivery system for ocular implant |
WO2013170195A1 (en) * | 2012-05-11 | 2013-11-14 | Medicus Biosciences, Llc | Biocompatible hydrogel treatments for retinal detachment |
GB2517921B (en) * | 2013-09-04 | 2015-12-16 | Duckworth & Kent Ltd | Device for use in a delivery of ophthalmic lenses |
US20140323995A1 (en) * | 2013-04-24 | 2014-10-30 | Transcend Medical, Inc. | Targeted Drug Delivery Devices and Methods |
US9554939B1 (en) * | 2013-11-27 | 2017-01-31 | Richard Breazeale | Magnetic retinal patch |
US10010447B2 (en) * | 2013-12-18 | 2018-07-03 | Novartis Ag | Systems and methods for subretinal delivery of therapeutic agents |
US10849788B2 (en) * | 2015-03-19 | 2020-12-01 | University Of Southern California | Polymer substrate retinal patch coated with adhesives |
-
2016
- 2016-12-08 EP EP16819176.5A patent/EP3389576B1/en active Active
- 2016-12-08 CA CA3006032A patent/CA3006032A1/en active Pending
- 2016-12-08 JP JP2018530506A patent/JP6930975B2/ja active Active
- 2016-12-08 CN CN201680073247.3A patent/CN108366875A/zh active Pending
- 2016-12-08 WO PCT/IB2016/057439 patent/WO2017103744A1/en active Application Filing
- 2016-12-08 US US15/372,691 patent/US20170165109A1/en not_active Abandoned
- 2016-12-08 AU AU2016370711A patent/AU2016370711B2/en active Active
-
2021
- 2021-06-02 JP JP2021093263A patent/JP7177887B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2021126534A (ja) | 2021-09-02 |
JP2019501701A (ja) | 2019-01-24 |
AU2016370711A1 (en) | 2018-06-07 |
CA3006032A1 (en) | 2017-06-22 |
US20170165109A1 (en) | 2017-06-15 |
WO2017103744A1 (en) | 2017-06-22 |
CN108366875A (zh) | 2018-08-03 |
EP3389576A1 (en) | 2018-10-24 |
EP3389576B1 (en) | 2022-03-23 |
JP7177887B2 (ja) | 2022-11-24 |
AU2016370711B2 (en) | 2021-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6930975B2 (ja) | 網膜裂孔をシーリングするためのパッチならびに関連するデバイス、システム、および方法 | |
JP6253652B2 (ja) | 調節可能フィラメントを伴う眼科外科手術用デバイス | |
JP7497406B2 (ja) | 眼球インプラントシステム | |
ES2871138T3 (es) | Aparato para la administración supracoroidea de agente terapéutico | |
CN107223042B (zh) | 治疗剂递送装置 | |
ES2961846T3 (es) | Aparato de fijación ocular para una guía de catéter de aguja tangencial subretiniana e introductor | |
US5318560A (en) | Laser delivery system | |
JP2012515627A (ja) | 網膜下アクセス装置 | |
JP2018521736A (ja) | 照明式眼科用輸液ライン並びに関連するデバイス、システム及び方法 | |
JP2012515626A (ja) | 流体吸引装置 | |
JP2008307384A (ja) | カニューレ | |
KR20210038578A (ko) | 물질의 타겟화된 전달을 위한 디바이스 및 방법 | |
US20050148948A1 (en) | Sutureless ophthalmic drug delivery system and method | |
US20190216645A1 (en) | Surgical device for ab-externo sub-retinal fluid drainage | |
KR101622839B1 (ko) | 안과 수술용 조명기구 | |
JP6470738B2 (ja) | 治療器具 | |
JP2014014398A (ja) | 手術器具本発明は、移植手術に用いられる手術器具に関する。 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20191118 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20191227 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20200116 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20200212 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20201023 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20201027 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210107 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20210209 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210602 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20210602 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20210615 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20210622 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210713 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210812 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6930975 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |